PCVX - Vaxcyte, Inc.
59.29
1.040 1.754%
Share volume: 1,445,172
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$58.25
1.04
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-06-2024 | 11-05-2024 | 02-25-2025 | 05-07-2025 | 11-04-2025 | 02-24-2026 | |
| Assets | ||||||||
| Total Assets | 2.091 B | 2.087 B | 3.560 B | 3.511 B | 3.378 B | 3.172 B | 3.003 B | |
| Current Assets | 1.517 B | 1.481 B | 2.214 B | 1.788 B | 1.717 B | 1.767 B | 1.627 B | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 875.006 M | 934.027 M | 1.130 B | 1.359 B | 1.325 B | 1.430 B | 1.387 B | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 611.512 M | 518.670 M | 1.050 B | 387.878 M | 346.850 M | 281.080 M | 173.959 M | |
| Total Non-current Assets | 413.247 M | 399.243 M | 1.093 B | 1.388 B | 1.279 B | 959.256 M | 881.664 M | |
| Property Plant Equipment | 84.835 M | 125.973 M | 163.243 M | 198.045 M | 217.155 M | 253.486 M | 257.370 M | |
| Other Assets | 489.398 M | 479.815 M | 1.183 B | 1.525 B | 1.444 B | 1.151 B | 1.118 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 2.091 B | 2.087 B | 3.560 B | 3.511 B | 3.378 B | 3.172 B | 3.003 B | |
| Total liabilities | 107.322 M | 101.135 M | 142.112 M | 205.499 M | 178.077 M | 278.718 M | 317.207 M | |
| Total current liabilities | 87.104 M | 82.847 M | 123.790 M | 140.180 M | 96.996 M | 200.046 M | 205.750 M | |
| Accounts Payable | 21.717 M | 10.466 M | 18.219 M | 48.452 M | 20.514 M | 48.962 M | 70.904 M | |
| Other liabilities | 20.218 M | 18.288 M | 18.322 M | 65.319 M | 81.081 M | 78.672 M | 111.457 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 20.218 M | 18.288 M | 18.322 M | 65.319 M | 81.081 M | 78.672 M | 111.457 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.984 B | 1.986 B | 3.418 B | 3.306 B | 3.200 B | 2.893 B | 2.686 B | |
| Common stock | 3.001 B | 3.132 B | 4.669 B | 4.698 B | 4.729 B | 4.800 B | 4.839 B | |
| Retained earnings | -1.019 B | -1.148 B | -1.251 B | -1.388 B | -1.529 B | -1.908 B | -2.155 B |